euNetworks Acquires Inland Fibre Telecom
euNetworks Group Limited (“euNetworks”) Europe’s bandwidth infrastructure provider, today announced that its subsidiary euNetworks Ireland Private Fiber Limited, acquired 100% of the shares of Inland Fibre Telecom. (“Inland Fibre”), a company headquartered in Dublin, Ireland.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151106005064/en/
As a leading bandwidth provider in Dublin, euNetworks has owned and operated a fibre based city network for a number of years with a local team and office to support existing customers. The addition of 130km to the network means euNetworks further strengthens its Dublin market offering at a time when demand for bandwidth solutions continues to grow.
“The acquisition of Inland Fibre has added further uniqueness to our fibre footprint in Dublin, creating new resilient routes in and out of some key business parks, as well as connecting important data centres,” said Brady Rafuse, Chief Executive Officer of euNetworks. “This is a highly complementary business to euNetworks and further strengthens our already dominant position in Dublin.”
“euNetworks has relationships with the majority of Inland Fibre’s customers today and are delighted to be working more closely with them supporting their bandwidth needs,” said Rafuse. “Integration of the networks is largely complete, delivering immediate value to customers from the combined footprint.”
“We are delighted that the assets of Inland Fibre were acquired by euNetworks, a company firmly established and committed to the Irish market,” said Jim McMahon, founder and Director at Inland Fibre Telecom Limited. “Their bandwidth offering both in Dublin and across Western Europe is certainly market leading and their approach to aligning network development and investment with customer needs is refreshing.”
The Inland Fibre network offers a number of unique features in the market, with routes along the canalways, comprehensive diversity options to key data centres in the city and access to business parks in Maynooth and Naas.
euNetworks is a bandwidth infrastructure provider, owning and operating 13 fibre based metropolitan networks across Europe connected with a high capacity intercity backbone covering 45 cities in 10 countries. The company leads the market in data centre connectivity, directly connecting over 260 in Europe today. euNetworks is also a leading cloud connectivity provider, connecting 12 cloud platforms. The company offers a portfolio of metropolitan and long haul services including Dark Fibre, Metro Wavelengths, Wavelengths, Ethernet, and Internet. Media, finance, enterprise and carrier customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfill their high bandwidth needs.
euNetworks Group Limited is headquartered in London. For further information please visit www.eunetworks.com.
Press and Investors:
Senior Director, Marketing
office: +44 20 7952 1338
mobile: +44 7717 896 446
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
BearingPoint: How Firms Transform into Digital Superpowers22.2.2018 08:30 | Pressemelding
Digital disruption has left Europe’s leading companies struggling to sustain growth and competitive advantage. Groundbreaking new research reveals how European companies can learn from US digital superpowers to speed up adoption of business model innovation, drive new revenues and get greater value from their core business. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222005241/en/ Diversifying business model Portfolio (Graphic: Business Wire) Today, firms that adopt a portfolio of business models which are asset light and include network effects are perceived by investors and the market as most likely to generate future growth. They therefore have a much higher market value in comparison to companies with traditional business models. Companies who diversified their business models improved their valuation in 2016 by 65% in comparison to those who maintained a mono-business model. Furthermore, between 2011-2016 they mana
Eli Global to Acquire Lead Generation Marketplace Finanzen22.2.2018 08:00 | Pressemelding
Eli Global LLC (“Eli”) today announced that an affiliate has entered into a definitive agreement to acquire finanzen.de AG and its subsidiaries (collectively, “Finanzen” or the “company”) from Blackfin Capital Partners (“Blackfin”) and Finanzen’s founders. Based in Berlin, Germany, Finanzen is the leading European online marketplace for retail customer leads in the finance and insurance sectors. The company connects lead generators such as online price comparison sites with lead buyers such as independent financial advisors and insurance agents. The company also acts as an online broker for certain insurance products. “Finanzen has done an impressive job creating a scalable technology platform poised to benefit from industry trends,” said George Luecke, global manager of Eli’s newly established insurance services portfolio and co-CEO of Global Bankers Insurance Group, which represents Eli’s life and annuity carrier division (“GBIG”). “We look forward to a long-term future with the comp
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage22.2.2018 06:00 | Pressemelding
Ferring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative, today announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO). CHAMPION is investigating whether Ferring’s proprietary and heat-stable carbetocin could offer a new solution to prevent excessive bleeding after childbirth (postpartum haemorrhage or PPH).2,3 Involving nearly 30,000 women in 10 countries, it is the largest clinical trial ever conducted in PPH.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221006496/en/ Each year, 14 million mothers are affected by PPH.4 As the leading direct cause of maternal mortality, 480,000 mothers died from PPH between 2003-09.1 Even when women survive, PPH can result in the need for serious medical interventions, including surgica
The Nippon Foundation: Project to Map Ocean Floor by 2030 Now Operational22.2.2018 05:00 | Pressemelding
The Nippon Foundation Chairman Yohei Sasakawa announced at a press conference today that The Nippon Foundation – GEBCO Seabed 2030 Project is now operational. The Project will realize Mr. Sasakawa’s vision of mapping the entire ocean floor by 2030. The Nippon Foundation has pledged US$2 million annually, and is calling for additional support from the global ocean community. Mr. Sasakawa noted, “The Nippon Foundation alone cannot achieve the objectives of this ambitious project. We will need the support of diverse stakeholders, including maritime corporations and technical experts. It is crucial that the ocean community comes together to achieve this goal”. He was joined by leading ocean-mapping experts, who emphasized that understanding the bathymetry of the global ocean is imperative for improving maritime navigation, and also for enhancing our ability to predict climate change and monitor marine biodiversity and resources. A comprehensive map of the seafloor will assist global effort
Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis21.2.2018 21:01 | Pressemelding
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it is initiating the first Phase 3 study of VX-659, tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation. The study will enroll 360 patients, and the primary endpoint of the study is the mean absolute change from baseline in percent predicted forced expiratory volume in one second (ppFEV1) at week four of treatment. The study is designed to support the submission of a New Drug Application (NDA) in the U.S. using data from the 4-week primary efficacy endpoint together with safety data through 12 weeks of treatment. “Our goal is to bring the best triple combination to patients as rapidly as possible, and this first Phase 3 study of VX-659 in combination with tezacaftor and ivacaftor is a significant step toward that goal,” said Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical
Universal Laser Systems® Expands Portfolio of Laser Material Processing Systems with the ULTRA Platform Series21.2.2018 18:00 | Pressemelding
ULTRA platform-based laser systems are designed and ideally suited for precision laser cutting, laser ablation, and laser surface modification in manufacturing, research and development, academic research and prototyping environments. Major features of the series include rapid, high-accuracy laser beam positioning, and the flexibility to be configured with 9.3 and 10.6 µm CO2 lasers and 1.06 µm fiber lasers. All lasers are air-cooled in a range of power from 10 to 150 watts for CO2 and 40 to 50 watts for fiber lasers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005364/en/ The ULTRA 9MW offers MultiWave processing of thin materials. (Photo: Business Wire) The variety of wavelengths and power ranges make the ULTRA platforms highly effective in the areas of organic material modification, including plastic films, industrial fabrics, engineering plastics, laminating adhesives, composite materials, and many others utilized